Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Non-Laboratory-based Cannabis Testing Market

Non-Laboratory-based Cannabis Testing Market Size

Report ID: GMI6901
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Non-Laboratory-based Cannabis Testing Market Size

Non-Laboratory-Based Cannabis Testing Market accounted for USD 46.5 million in 2022 and is anticipated to reach USD 186.8 million by 2032 with a CAGR of 14.5%. This substantial growth is attributed to several key factors, including the increasing legalization of cannabis for medical purposes and the expanding research efforts exploring various medical applications of cannabis.

To get key market trends

Download Free Sample

Portable non-laboratory-based cannabis testing devices offer distinct advantages by significantly improving the accessibility of cannabis testing capabilities. These compact and portable devices empower a wide range of users, including consumers, growers, and dispensaries, as they enable testing to take place outside of traditional laboratory settings. Their portability allows for on-site testing at various locations, including cultivation facilities, dispensaries, and even outdoor cultivation sites.

Non-laboratory-based cannabis testing refers to portable/handheld devices designed for on-the-go assessment of various aspects of cannabis testing [Tetrahydrocannabinol (THC), Cannabidiol (CBD), etc.] without the need for a traditional laboratory setup. These portable devices are often used to quickly evaluate different characteristics of cannabis, including potency, quality, safety, and authenticity.

Non-Laboratory-based Cannabis Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Non-Laboratory-based Cannabis Testing Market Size in 2022:	USD 46.5 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	14.5%
2032 Value Projection:	USD 186.8 Million
Historical Data for:	2018 to 2022
No. of Pages:	112
Tables, Charts & Figures:	196
Segments covered:	Technology, Test Type, and Region
Growth Drivers:	Growing legalization of cannabis for medical purposes Increasing research on various medical use of cannabis
Pitfalls & Challenges:	Lack of uniformity in quality standards

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global non-laboratory-based cannabis testing industry was worth USD 46.5 million in 2022 and is anticipated to reach USD 186.8 million by 2032, attributed to the increasing legalization of cannabis for medical purposes and the expanding research efforts exploring various medical applications of cannabis.

The spectroscopy segment is expected to continue growing at a rate of 14.9% from 2023 to 2032 as spectroscopy enables simultaneous measuring of various parameters in cannabis samples, including the levels of cannabinoids such as THC and CBD, moisture content, and the presence of contaminants.

Europe non-laboratory-based cannabis testing market is projected to reach USD 82.6 million by 2032, owing to focus on control assessments for ensuring regulatory standards are met and comply with Germany's strict legal requirements.

Purpl Scientific, Orange Photonics, Inc., GemmaCert, MyDx, Inc., tCheck, ALPHA-CAT, and Sage Analytics, Inc.